Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Erectile Dysfunction Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period.
This report presents the market size and development trends by detailing the Erectile Dysfunction Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Erectile Dysfunction Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Erectile Dysfunction Drugs industry and will help you to build a panoramic view of the industrial development.
Erectile Dysfunction Drugs Market, By Type:
Sildenafil Citrate (Viagra)
Vardenafil (Levitra/Staxyn)
Tadalafil (Cialis)
Udenafil (Zydena)
Lodenafil Carbonate (Helleva)
Stendra/Spedra (Avanafil)
Mirodenafil (Mvix)
Others
Erectile Dysfunction Drugs Market, By Application:
Hospital Pharmacies
Retail Pharmacies
Online Sales
Some of the leading players are as follows:
S.K. Chemicals Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Bayer AG
Vivus, Inc.
GlaxoSmithKline plc,, Inc.
Pfizer, Inc.
Cristália
Meda Pharmaceuticals, Inc
Dong-A-Pharmaceutical Co., Ltd.
Apricus Biosciences
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Erectile Dysfunction Drugs Market: Technology Type Analysis
-
4.1 Erectile Dysfunction Drugs Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Erectile Dysfunction Drugs Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Sildenafil Citrate (Viagra)
4.3.2 Vardenafil (Levitra/Staxyn)
4.3.3 Tadalafil (Cialis)
4.3.4 Udenafil (Zydena)
4.3.5 Lodenafil Carbonate (Helleva)
4.3.6 Stendra/Spedra (Avanafil)
4.3.7 Mirodenafil (Mvix)
4.3.8 Others
5 Erectile Dysfunction Drugs Market: Product Analysis
-
5.1 Erectile Dysfunction Drugs Product Market Share Analysis, 2018 & 2026
-
5.2 Erectile Dysfunction Drugs Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Erectile Dysfunction Drugs Market: Application Analysis
-
6.1 Erectile Dysfunction Drugs Application Market Share Analysis, 2018 & 2026
-
6.2 Erectile Dysfunction Drugs Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Sales
7 Erectile Dysfunction Drugs Market: Regional Analysis
-
7.1 Erectile Dysfunction Drugs Regional Market Share Analysis, 2018 & 2026
-
7.2 Erectile Dysfunction Drugs Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 S.K. Chemicals Co., Ltd.
9.1.1 S.K. Chemicals Co., Ltd. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Teva Pharmaceutical Industries Ltd.
9.2.1 Teva Pharmaceutical Industries Ltd. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bayer AG
9.3.1 Bayer AG Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Vivus, Inc.
9.4.1 Vivus, Inc. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 GlaxoSmithKline plc,, Inc.
9.5.1 GlaxoSmithKline plc,, Inc. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Pfizer, Inc.
9.6.1 Pfizer, Inc. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Cristália
9.7.1 Cristália Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Meda Pharmaceuticals, Inc
9.8.1 Meda Pharmaceuticals, Inc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Dong-A-Pharmaceutical Co., Ltd.
9.9.1 Dong-A-Pharmaceutical Co., Ltd. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Apricus Biosciences
9.10.1 Apricus Biosciences Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 72 Figures and 128 Tables)
Figure Sildenafil Citrate (Viagra) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Vardenafil (Levitra/Staxyn) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Tadalafil (Cialis) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Udenafil (Zydena) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Lodenafil Carbonate (Helleva) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Stendra/Spedra (Avanafil) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Mirodenafil (Mvix) Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Others Erectile Dysfunction Drugs market, 2015 - 2026 (USD Million)
Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)
Figure Retail Pharmacies market, 2015 - 2026 (USD Million)
Figure Online Sales market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Erectile Dysfunction Drugs market, by country, 2015 - 2026 (USD Million)
-
Table North America Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table North America Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table North America Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Canada Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Canada Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Europe Erectile Dysfunction Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Europe Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Europe Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Europe Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Germany Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Germany Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table France Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table France Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Italy Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Italy Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Spain Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Spain Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Erectile Dysfunction Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table China Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table China Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Japan Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Japan Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table India Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table India Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Erectile Dysfunction Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table MEA Erectile Dysfunction Drugs market, by country, 2015 - 2026 (USD Million)
-
Table MEA Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table MEA Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table MEA Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Erectile Dysfunction Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Erectile Dysfunction Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Erectile Dysfunction Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table S.K. Chemicals Co., Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Vivus, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline plc,, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cristália Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Meda Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dong-A-Pharmaceutical Co., Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Apricus Biosciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
